{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:18:58Z","timestamp":1793884738317,"version":"4.7.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017585","name":"The First Hospital of Jilin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017585","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.lfs.2024.122539","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T02:18:25Z","timestamp":1709000305000},"page":"122539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Exploring the multifaceted effects of Interleukin-1 in lung cancer: From tumor development to immune modulation"],"prefix":"10.1016","volume":"342","author":[{"given":"Mingbo","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiyu","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.122539_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.984349","article-title":"Lung cancer in never smokers: tumor immunology and challenges for immunotherapy","volume":"13","author":"de Alencar","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2024.122539_bb0010","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.lfs.2024.122539_bb0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ccell.2021.04.011","article-title":"Interleukin-1 in tumor progression, therapy, and prevention","volume":"39","author":"Garlanda","year":"2021","journal-title":"Cancer Cell"},{"issue":"Pt 2","key":"10.1016\/j.lfs.2024.122539_bb0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.semcancer.2022.05.002","article-title":"The IL-1 family in tumorigenesis and antitumor immunity","volume":"86","author":"Sun","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122539_bb0025","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/imr.12614","article-title":"IL-1 and IL-1 regulatory pathways in cancer progression and therapy","volume":"281","author":"Mantovani","year":"2018","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.lfs.2024.122539_bb0035","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"issue":"14","key":"10.1016\/j.lfs.2024.122539_bb0040","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.lfs.2024.122539_bb0045","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.lfs.2024.122539_bb0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","article-title":"Diverging inflammasome signals in tumorigenesis and potential targeting","volume":"19","author":"Karki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2024.122539_bb0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","article-title":"The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions","volume":"25","author":"Apte","year":"2006","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.lfs.2024.122539_bb0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","article-title":"Smoldering and polarized inflammation in the initiation and promotion of malignant disease","volume":"7","author":"Balkwill","year":"2005","journal-title":"Cancer Cell"},{"issue":"7043","key":"10.1016\/j.lfs.2024.122539_bb0065","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/435752a","article-title":"Cancer: inflammation by remote control","volume":"435","author":"Mantovani","year":"2005","journal-title":"Nature"},{"issue":"7203","key":"10.1016\/j.lfs.2024.122539_bb0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.lfs.2024.122539_bb0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1044-579X(02)00014-7","article-title":"Interleukin-1--a major pleiotropic cytokine in tumor-host interactions","volume":"12","author":"Apte","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lfs.2024.122539_bb0080","doi-asserted-by":"crossref","first-page":"36107","DOI":"10.1038\/srep36107","article-title":"Targeting inflammasome\/IL-1 pathways for cancer immunotherapy","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.lfs.2024.122539_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082155","article-title":"Interleukin-1 Beta-a friend or foe in malignancies?","volume":"19","author":"Bent","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"105","key":"10.1016\/j.lfs.2024.122539_bb0090","first-page":"cm1","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci. Signal."},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10555-010-9223-6","article-title":"Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity","volume":"29","author":"DeNardo","year":"2010","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.lfs.2024.122539_bb0105","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2024.122539_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/BD-2007-26107","article-title":"Chemokine networks and breast cancer metastasis","volume":"26","author":"Karnoub","year":"2006","journal-title":"Breast Dis."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.12620","article-title":"Interleukin 1 gene polymorphism and susceptibility to disease","volume":"281","author":"Khazim","year":"2018","journal-title":"Immunol. Rev."},{"issue":"17","key":"10.1016\/j.lfs.2024.122539_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176009","article-title":"Roles of IL-1 in Cancer: from tumor progression to resistance to targeted therapies","volume":"21","author":"Gelfo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2024.122539_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099568","article-title":"Tumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophages","volume":"9","author":"Watari","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lfs.2024.122539_bb0130","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1073\/pnas.0437939100","article-title":"IL-1 is required for tumor invasiveness and angiogenesis","volume":"100","author":"Voronov","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.lfs.2024.122539_bb0135","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1158\/0008-5472.CAN-06-2956","article-title":"Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors","volume":"67","author":"Krelin","year":"2007","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2024.122539_bb0140","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ccell.2019.04.003","article-title":"Targeting TMEM176B enhances antitumor immunity and augments the efficacy of immune checkpoint blockers by unleashing Inflammasome activation","volume":"35","author":"Segovia","year":"2019","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.lfs.2024.122539_bb0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.it.2013.03.008","article-title":"MyD88 and its divergent toll in carcinogenesis","volume":"34","author":"Salcedo","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2024.122539_bb0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mgene.2013.12.002","article-title":"Association of interleukin 1 beta (IL-1\u03b2) polymorphism with mRNA expression and risk of non small cell lung cancer","volume":"2","author":"Bhat","year":"2014","journal-title":"Meta Gene"},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.canlet.2005.05.015","article-title":"Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer","volume":"236","author":"Hu","year":"2006","journal-title":"Cancer Lett."},{"issue":"13","key":"10.1016\/j.lfs.2024.122539_bb0160","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1158\/0008-5472.CAN-07-0370","article-title":"Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer","volume":"67","author":"Engels","year":"2007","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.lfs.2024.122539_bb0165","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.171.12.6448","article-title":"Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness","volume":"171","author":"Song","year":"2003","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.lfs.2024.122539_bb0170","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-14-0960","article-title":"IL-1\u03b2-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis","volume":"74","author":"Wang","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2024.122539_bb0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1479-5876-4-48","article-title":"Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment","volume":"4","author":"Lewis","year":"2006","journal-title":"J. Transl. Med."},{"issue":"10105","key":"10.1016\/j.lfs.2024.122539_bb0180","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2024.122539_bb0185","doi-asserted-by":"crossref","first-page":"1192861","DOI":"10.3389\/fimmu.2023.1192861","article-title":"Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1\u03b2","volume":"14","author":"Hirayama","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.lfs.2024.122539_bb0190","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/2159-8290.CD-20-1285","article-title":"Resolving the spatial and cellular architecture of lung adenocarcinoma by multiregion single-cell sequencing","volume":"11","author":"Sinjab","year":"2021","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.lfs.2024.122539_bb0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/2326-6066.CIR-20-0431","article-title":"IL1\u03b2 promotes immune suppression in the tumor microenvironment independent of the Inflammasome and Gasdermin D","volume":"9","author":"Kiss","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.lfs.2024.122539_bb0200","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fimmu.2013.00391","article-title":"The interleukin-1\u03b1 precursor is biologically active and is likely a key Alarmin in the IL-1 family of cytokines","volume":"4","author":"Kim","year":"2013","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","article-title":"The lung microenvironment: an important regulator of tumour growth and metastasis","volume":"19","author":"Altorki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2024.122539_bb0210","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1378\/chest.106.4.1042","article-title":"Mononuclear cells in exudative malignant pleural effusions. Characterization of pleural phagocytic cells","volume":"106","author":"Gjomarkaj","year":"1994","journal-title":"Chest"},{"issue":"3 Pt 1","key":"10.1016\/j.lfs.2024.122539_bb0215","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1164\/ajrccm.156.3.9701122","article-title":"Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors","volume":"156","author":"Colasante","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0220","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"issue":"5876","key":"10.1016\/j.lfs.2024.122539_bb0225","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.lfs.2024.122539_bb0230","first-page":"98","article-title":"Chronic inflammation in cancer development","volume":"2","author":"Multhoff","year":"2011","journal-title":"Front. Immunol."},{"issue":"46","key":"10.1016\/j.lfs.2024.122539_bb0235","doi-asserted-by":"crossref","first-page":"81679","DOI":"10.18632\/oncotarget.20955","article-title":"MicroRNAs in lung cancer","volume":"8","author":"Castro","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.lfs.2024.122539_bb0240","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI23298","article-title":"Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth","volume":"115","author":"Nakao","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.lfs.2024.122539_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09953","article-title":"Prognosis value of IL-6, IL-8, and IL-1\u03b2 in serum of patients with lung cancer: a fresh look at interleukins as a biomarker","volume":"8","author":"Yan","year":"2022","journal-title":"Heliyon"},{"issue":"52","key":"10.1016\/j.lfs.2024.122539_bb0250","doi-asserted-by":"crossref","first-page":"85876","DOI":"10.18632\/oncotarget.13042","article-title":"Correlation between serum IL-1\u03b2 and miR-144-3p as well as their prognostic values in LUAD and LUSC patients","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0255","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.celrep.2016.05.085","article-title":"Neutrophil-derived IL-1\u03b2 impairs the efficacy of NF-\u03baB inhibitors against lung Cancer","volume":"16","author":"McLoed","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2024.122539_bb0260","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.lungcan.2018.06.015","article-title":"Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: local patterns and prognostic significance","volume":"122","author":"Millares","year":"2018","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2024.122539_bb0265","first-page":"413","article-title":"Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients","volume":"17","author":"De Vita","year":"1998","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2024.122539_bb0270","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/1097-0142(19940901)74:5<1546::AID-CNCR2820740509>3.0.CO;2-F","article-title":"Nitrite\/nitrate and cytokine levels in bronchoalveolar lavage fluid of lung cancer patients","volume":"74","author":"Arias-D\u00edaz","year":"1994","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-023-01407-7","article-title":"Involvement of inflammasomes in tumor microenvironment and tumor therapies","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.lfs.2024.122539_bb0280","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1097\/JTO.0b013e3181f387e4","article-title":"The role of inflammation in the pathogenesis of non-small cell lung cancer","volume":"5","author":"O\u2019Callaghan","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"5 Pt 1","key":"10.1016\/j.lfs.2024.122539_bb0285","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1164\/ajrccm.157.5.9707141","article-title":"Mechanisms in the pathogenesis of asbestosis and silicosis","volume":"157","author":"Mossman","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ccr.2009.12.008","article-title":"Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation","volume":"17","author":"Takahashi","year":"2010","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.lfs.2024.122539_bb0295","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","article-title":"Commensal microbiota promote lung Cancer development via \u03b3\u03b4 T cells","volume":"176","author":"Jin","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0300","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.chest.2019.04.114","article-title":"Common pathogenic mechanisms between idiopathic pulmonary fibrosis and lung Cancer","volume":"156","author":"Tzouvelekis","year":"2019","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.lfs.2024.122539_bb0305","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1513\/AnnalsATS.201807-481OC","article-title":"Idiopathic pulmonary fibrosis and lung Cancer. A systematic review and Meta-analysis","volume":"16","author":"Brown","year":"2019","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"12","key":"10.1016\/j.lfs.2024.122539_bb0310","first-page":"3786","article-title":"IL-1R1\/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice","volume":"117","author":"Gasse","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0315","first-page":"173","article-title":"Interleukin-1beta and tumour necrosis factor-alpha promote the transformation of human immortalised mesothelial cells by erionite","volume":"25","author":"Wang","year":"2004","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.lfs.2024.122539_bb0320","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1111\/cas.14523","article-title":"Tumor-associated macrophage-derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma","volume":"111","author":"Horio","year":"2020","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.lfs.2024.122539_bb0325","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.smim.2016.10.001","article-title":"The modern interleukin-1 superfamily: divergent roles in obesity","volume":"28","author":"Lee","year":"2016","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0330","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.169.1.469","article-title":"Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction","volume":"169","author":"Saijo","year":"2002","journal-title":"J. Immunol."},{"issue":"14","key":"10.1016\/j.lfs.2024.122539_bb0335","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1096\/fj.03-0329fje","article-title":"IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB\/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis","volume":"17","author":"Jung","year":"2003","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.lfs.2024.122539_bb0340","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/carcin\/bgr027","article-title":"Macrophages induce COX-2 expression in breast cancer cells: role of IL-1\u03b2 autoamplification","volume":"32","author":"Hou","year":"2011","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.lfs.2024.122539_bb0345","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/carcin\/bgs367","article-title":"Selective cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling","volume":"34","author":"Wang","year":"2013","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.lfs.2024.122539_bb0350","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1159\/000492687","article-title":"IL-1\u03b2-mediated up-regulation of WT1D via miR-144-3p and their synergistic effect with NF-\u03baB\/COX-2\/HIF-1\u03b1 pathway on cell proliferation in LUAD","volume":"48","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.lfs.2024.122539_bb0355","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2024.122539_bb0360","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.2147\/JIR.S319433","article-title":"Interleukin -1\u03b2 promotes lung adenocarcinoma growth and invasion through promoting glycolysis via p38 pathway","volume":"14","author":"Tan","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"3","key":"10.1016\/j.lfs.2024.122539_bb0365","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1158\/0008-5472.CAN-05-3317","article-title":"The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells","volume":"66","author":"Mukhopadhyay","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0370","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bcp.2006.09.018","article-title":"Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells","volume":"73","author":"Chen","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2024.122539_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/mc.20597","article-title":"Pachymic acid inhibits cell growth and modulates arachidonic acid metabolism in nonsmall cell lung cancer A549 cells","volume":"49","author":"Ling","year":"2010","journal-title":"Mol. Carcinog."},{"issue":"10","key":"10.1016\/j.lfs.2024.122539_bb0380","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1111\/jcmm.13178","article-title":"Dihydroberberine exhibits synergistic effects with sunitinib on NSCLC NCI-H460 cells by repressing MAP kinase pathways and inflammatory mediators","volume":"21","author":"Dai","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020221","article-title":"Sorafenib alleviates inflammatory signaling of tumor microenvironment in precancerous lung injuries","volume":"16","author":"Cicek","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0390","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BJ20091038","article-title":"Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1","volume":"427","author":"Newton","year":"2010","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0395","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1039\/C6FO01545J","article-title":"Immune enhancement effects and extraction optimization of polysaccharides from Citrus aurantium L","volume":"8","author":"Shen","year":"2017","journal-title":"var. amara Engl. Food Funct."},{"issue":"7","key":"10.1016\/j.lfs.2024.122539_bb0400","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.4049\/jimmunol.0901511","article-title":"The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis","volume":"183","author":"Carmi","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.122539_bb0405","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fphys.2014.00114","article-title":"The role IL-1 in tumor-mediated angiogenesis","volume":"5","author":"Voronov","year":"2014","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.lfs.2024.122539_bb0410","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","article-title":"Phenotype molding of stromal cells in the lung tumor microenvironment","volume":"24","author":"Lambrechts","year":"2018","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.lfs.2024.122539_bb0415","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/s41388-019-1099-5","article-title":"Targeting the IL-1\u03b2\/EHD1\/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC","volume":"39","author":"Huang","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2024.122539_bb0420","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3389\/fimmu.2019.01426","article-title":"IL-1 family cytokine regulation of vascular permeability and angiogenesis","volume":"10","author":"Fahey","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122539_bb0425","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/ATVBAHA.111.243477","article-title":"Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells","volume":"32","author":"Jagielska","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.lfs.2024.122539_bb0430","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1182\/blood.V84.12.4242.bloodjournal84124242","article-title":"Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism","volume":"84","author":"Kaplanski","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0435","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10555-010-9229-0","article-title":"Why not treat human cancer with interleukin-1 blockade?","volume":"29","author":"Dinarello","year":"2010","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.lfs.2024.122539_bb0440","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"issue":"15","key":"10.1016\/j.lfs.2024.122539_bb0445","first-page":"4771","article-title":"Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice","volume":"50","author":"Giavazzi","year":"1990","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0450","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41467-020-15188-x","article-title":"Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs","volume":"11","author":"Pein","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.lfs.2024.122539_bb0455","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/ijc.30538","article-title":"Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1\u03b2-mediated increase in E-selectin expression","volume":"140","author":"Shi","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0460","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jnci\/83.2.119","article-title":"Effect of interleukin-1-beta on metastasis formation in different tumor systems","volume":"83","author":"Bani","year":"1991","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.lfs.2024.122539_bb0465","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1349-7006.2003.tb01428.x","article-title":"Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules","volume":"94","author":"Yano","year":"2003","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0470","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41598-019-57285-y","article-title":"Chronic IL-1\u03b2-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.lfs.2024.122539_bb0475","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103180118","article-title":"Pharmacological inhibition of MDA-9\/Syntenin blocks breast cancer metastasis through suppression of IL-1\u03b2","volume":"118","author":"Pradhan","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.lfs.2024.122539_bb0480","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41556-018-0173-5","article-title":"IL-1\u03b2 inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization","volume":"20","author":"Casta\u00f1o","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2024.122539_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109018","article-title":"Melatonin inhibits lung metastasis of gastric cancer in vivo","volume":"117","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.lfs.2024.122539_bb0490","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/1078-0432.CCR-12-2927","article-title":"Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6","volume":"19","author":"Van Tubergen","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0495","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12943-016-0564-9","article-title":"Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-\u03baB-dependent activation of snail and epithelial mesenchymal transition","volume":"15","author":"Feng","year":"2016","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0500","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2012.07.009","article-title":"Interleukin-1 beta and transforming growth factor-beta 3 cooperate to activate matrix metalloproteinase expression and invasiveness in A549 lung adenocarcinoma cells","volume":"325","author":"Petrella","year":"2012","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.lfs.2024.122539_bb0505","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1476-5381.2010.00858.x","article-title":"IL-1beta induces expression of matrix metalloproteinase-9 and cell migration via a c-Src-dependent, growth factor receptor transactivation in A549 cells","volume":"160","author":"Cheng","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0510","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jcp.21669","article-title":"IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1\/2, and NF-kappaB in A549 cells","volume":"219","author":"Cheng","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0515","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13046-023-02748-4","article-title":"Pulmonary interleukin 1 beta\/serum amyloid A3 axis promotes lung metastasis of hepatocellular carcinoma by facilitating the pre-metastatic niche formation","volume":"42","author":"Zhang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.lfs.2024.122539_bb0520","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.4049\/jimmunol.1002901","article-title":"Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis","volume":"186","author":"Carmi","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0525","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41698-021-00244-6","article-title":"Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade","volume":"6","author":"Wang","year":"2022","journal-title":"NPJ Precis. Oncol."},{"issue":"21","key":"10.1016\/j.lfs.2024.122539_bb0530","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2024.122539_bb0535","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/ITT.S163924","article-title":"William Bradley Coley, MD, and the phenomenon of spontaneous regression","volume":"7","author":"Vernon","year":"2018","journal-title":"Immunotargets Ther."},{"issue":"9276","key":"10.1016\/j.lfs.2024.122539_bb0540","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(01)05369-7","article-title":"Infection and cancer","volume":"358","author":"Haux","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.lfs.2024.122539_bb0545","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1165\/rcmb.2008-0198OC","article-title":"Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model","volume":"40","author":"Moghaddam","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"24","key":"10.1016\/j.lfs.2024.122539_bb0550","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1158\/0008-5472.CAN-19-3176","article-title":"Inhibition of IL1\u03b2 by Canakinumab may be effective against diverse molecular subtypes of lung Cancer: an exploratory analysis of the CANTOS trial","volume":"80","author":"Wong","year":"2020","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.lfs.2024.122539_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411547","article-title":"Comprehensive review: unveiling the pro-oncogenic roles of IL-1\u00df and PD-1\/PD-L1 in NSCLC development and targeting their pathways for clinical management","volume":"24","author":"Castillo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2024.122539_bb0560","first-page":"1212","article-title":"Interleukin 1 as an adjuvant for active specific immunotherapy in a murine tumor model","volume":"50","author":"McCune","year":"1990","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0565","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijc.23474","article-title":"Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma","volume":"123","author":"Ho","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0570","first-page":"173","article-title":"Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide","volume":"18","author":"Cao","year":"1999","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.lfs.2024.122539_bb0575","first-page":"171","article-title":"The antiproliferative effect of trans-retinoic acid is associated with selective induction of interleukin-1 beta, a cytokine that directly inhibits growth of lung cancer cells","volume":"8","author":"Ross","year":"1996","journal-title":"Oncol. Res."},{"issue":"16","key":"10.1016\/j.lfs.2024.122539_bb0580","doi-asserted-by":"crossref","first-page":"E3673","DOI":"10.1073\/pnas.1803291115","article-title":"Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis","volume":"115","author":"Zhao","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2024.122539_bb0585","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.997319","article-title":"A pyroptosis-related gene model and its correlation with the microenvironment of lung adenocarcinoma: a bioinformatics analysis and experimental verification","volume":"13","author":"Dong","year":"2022","journal-title":"Front. Genet."},{"issue":"10","key":"10.1016\/j.lfs.2024.122539_bb0590","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.lfs.2024.122539_bb0595","first-page":"519","article-title":"Systemic chemotherapy alters interleukin-1 beta and its receptor antagonist production by human alveolar macrophages in lung cancer patients","volume":"8","author":"Haku","year":"1996","journal-title":"Oncol. Res."},{"issue":"8","key":"10.1016\/j.lfs.2024.122539_bb0600","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1016\/S0021-9258(18)69027-1","article-title":"The precursor of interleukin-1 alpha is phosphorylated at residue serine 90","volume":"263","author":"Beuscher","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.lfs.2024.122539_bb0605","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.4049\/jimmunol.140.7.2279","article-title":"Phosphorylation of intracellular precursors of human IL-1","volume":"140","author":"Kobayashi","year":"1988","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.lfs.2024.122539_bb0610","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.1073\/pnas.90.15.7245","article-title":"The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece","volume":"90","author":"Stevenson","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2024.122539_bb0615","doi-asserted-by":"crossref","first-page":"14756","DOI":"10.1038\/srep14756","article-title":"IL-1\u03b1 is a DNA damage sensor linking genotoxic stress signaling to sterile inflammation and innate immunity","volume":"5","author":"Cohen","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2024.122539_bb0620","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.immuni.2012.01.018","article-title":"Inflammasome activators induce interleukin-1\u03b1 secretion via distinct pathways with differential requirement for the protease function of caspase-1","volume":"36","author":"Gross","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010092","article-title":"IL-1\u03b1 processing, signaling and its role in Cancer progression","volume":"10","author":"Chiu","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0630","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/toxsci\/kfi251","article-title":"Induction of fibroblast growth factor-9 and interleukin-1alpha gene expression by motorcycle exhaust particulate extracts and benzo(a)pyrene in human lung adenocarcinoma cells","volume":"87","author":"Ueng","year":"2005","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.lfs.2024.122539_bb0635","first-page":"653","article-title":"Ionizing radiation-induced IL-1 alpha, IL-6 and GM-CSF production by human lung cancer cells","volume":"107","author":"Zhang","year":"1994","journal-title":"Chin. Med. J."},{"issue":"11","key":"10.1016\/j.lfs.2024.122539_bb0640","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.ajpath.2015.07.009","article-title":"Human lung cancer-derived immunosuppressive plasmacytoid dendritic cells release IL-1\u03b1 in an AIM2 inflammasome-dependent manner","volume":"185","author":"Sorrentino","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122539_bb0645","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4049\/jimmunol.149.5.1758","article-title":"Decay-accelerating factor functions as a signal transducing molecule for human monocytes","volume":"149","author":"Shibuya","year":"1992","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122539_bb0650","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imr.12615","article-title":"Function and regulation of IL-1\u03b1 in inflammatory diseases and cancer","volume":"281","author":"Malik","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lfs.2024.122539_bb0655","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fimmu.2012.00290","article-title":"The transcription of the alarmin cytokine interleukin-1 alpha is controlled by hypoxia inducible factors 1 and 2 alpha in hypoxic cells","volume":"3","author":"Rider","year":"2012","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.lfs.2024.122539_bb0660","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1084\/jem.20101355","article-title":"IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis","volume":"209","author":"Cataisson","year":"2012","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.lfs.2024.122539_bb0665","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.immuni.2019.03.003","article-title":"The coagulation and immune systems are directly linked through the activation of interleukin-1\u03b1 by thrombin","volume":"50","author":"Burzynski","year":"2019","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.lfs.2024.122539_bb0670","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezad313","article-title":"Prognostic assessment of lung adenocarcinoma patients with early-staging diseases: a nomogram based on coagulation-related factors","volume":"64","author":"Wu","year":"2023","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"2","key":"10.1016\/j.lfs.2024.122539_bb0675","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00262-021-02997-2","article-title":"Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab","volume":"71","author":"Jo","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.lfs.2024.122539_bb0680","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1470-2045(14)70155-X","article-title":"MABp1, a first-in-class true human antibody targeting interleukin-1\u03b1 in refractory cancers: an open-label, phase 1 dose-escalation and expansion study","volume":"15","author":"Hong","year":"2014","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122539_bb0685","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1470-2045(14)70164-0","article-title":"Interleukin-1\u03b1 neutralisation in patients with cancer","volume":"15","author":"Dinarello","year":"2014","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122539_bb0695","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201847575","article-title":"The emerging roles of inflammasome-dependent cytokines in cancer development","volume":"20","author":"Van Gorp","year":"2019","journal-title":"EMBO Rep."},{"issue":"5","key":"10.1016\/j.lfs.2024.122539_bb0700","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2024.122539_bb0705","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122539_bb0710","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1073\/pnas.0915018107","article-title":"Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation","volume":"107","author":"Cohen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.lfs.2024.122539_bb0715","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/rheumatology\/37.7.797","article-title":"Circulating levels of IL-1beta, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giant cell arteritis and rheumatoid arthritis","volume":"37","author":"Pountain","year":"1998","journal-title":"Br. J. Rheumatol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524001280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524001280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:17:32Z","timestamp":1758403052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524001280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":142,"alternative-id":["S0024320524001280"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122539","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the multifaceted effects of Interleukin-1 in lung cancer: From tumor development to immune modulation","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"122539"}}